Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/17/16 → 3/17/19 |
Funding
- Quintiles, Inc. (Prot #391402 // Prot #391402)
- Baxalta US Inc. (Prot #391402 // Prot #391402)
Prot #391402: A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects with Refractory Ovarian Cancer with Malignant Ascites
- Chae, Young Kwang (PD/PI)
Project: Research project